Note side effects and their severity
In part 2 well learn about how this impacted one patient
Data from the STEP [52] and SUSTAIN [53, 54] trials consistently demonstrate that the substantial weight loss achieved with semaglutide at doses of 0.5 mg, 1.0 mg, and 2.4 mg is largely independent of these symptoms, with less than 1% of the total weight loss benefit attributable to GI AEs
Choice between the two is usually driven by cardiovascular/renal risk profile, tolerability, availability, and cost not by weight loss magnitude
Alternative Postpartum Weight Management If you cant use GLP-1s due to breastfeeding, focus on gradual, sustainable weight loss with a maximum of 1-2 pounds per week
Deep vein thrombosis stood out